Characterization of various deformable liposomes with metronidazole

Drug Dev Ind Pharm. 2013 Mar;39(3):481-8. doi: 10.3109/03639045.2012.670247. Epub 2012 Mar 29.

Abstract

Objective: The aim of this study was to investigate various deformable liposomes for their potential application for the vaginal administration of metronidazole.

Materials and methods: Deformable liposomes composed of egg phosphatidylcholine (EPC) and various surfactants [sodium deoxycholate (SDCh), Tween 80 or Span 80] and conventional liposomes consisting of EPC and egg phosphatidylglycerol-sodium (EPG-Na) were prepared with and without metronidazole. Additionally, a freeze-thaw method was applied to both classes of vesicles (liposomes) containing the drug to improve its trapping capacity. All of the liposomes prepared were characterized and compared in terms of size, polydispersity, zeta potential, entrapment efficiency and their permeability on a Caco-2 cell monolayer.

Results and discussion: Conventional liposomes, both with and without metronidazole, were larger than the deformable vesicles. The presence of ethanol in the preparations of the elastic EPC/SDCh and EPC/Tween 80 liposomes was found to affect the particle size in terms of reducing this parameter. Different types of vesicles were compared for their trapping efficiency of metronidazole and the highest entrapment was observed with conventional liposomes. However, deformable EPC/SDCh liposomes were found to enhance the permeability of metronidazole more effectively than the conventional liposomes based on the in vitro model of the epithelial barrier.

Conclusion: These preliminary data indicate that EPC/SDCh liposomes may have a promising future in vaginal delivery of metronidazole. Therefore, additional investigations on elastic vesicles and their incorporation in a suitable vehicle should be considered to further evaluate their applicability in vaginal drug delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravaginal
  • Anti-Infective Agents / administration & dosage*
  • Drug Carriers / administration & dosage
  • Drug Carriers / chemistry*
  • Drug Delivery Systems*
  • Female
  • Humans
  • Liposomes / chemistry*
  • Metronidazole / administration & dosage*
  • Models, Theoretical
  • Particle Size

Substances

  • Anti-Infective Agents
  • Drug Carriers
  • Liposomes
  • Metronidazole